Specify a stock or a cryptocurrency in the search bar to get a summary
Gempharmatech Co. Ltd. A
688046GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company was founded in 2017 and is headquartered in Nanjing, China. Address: No. 12 Xuefu Road, Nanjing, China, 210032
Analytics
WallStreet Target Price
130.62 CNYP/E ratio
42.1471Dividend Yield
1.4 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688046
Dividend Analytics 688046
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
11 %Dividend History 688046
Stock Valuation 688046
Financials 688046
Results | 2019 | Dynamics |